$JAZZ Recent Headlines Why eBay is like a divorcee, and

New Post Public Reply Private Reply Replies (0) Message Board

Dec 14, 2014 at 11:11 AM

$JAZZ Recent Headlines

Why eBay is like a divorcee, and a pharma pick that’s setting up for a pop 8:46 a.m. Nov. 7, 2014 - Shawn Langlois
There’s good news for speculative growth traders 1:40 p.m. Sept. 2, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 1:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 7:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 9:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 10:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 1:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh

Jazz kicks off Fast Track review process for VOD med 1:28 p.m. Dec. 12, 2014 - Seeking Alpha
Insider Trading Alert - JAZZ, ARE And SCLN Traded By Insiders 11:30 a.m. Dec. 12, 2014 - TheStreet.com
JAZZ Pharmaceuticals Slips After Dosing Issue on JZP-386 - Analyst Blog 2:39 p.m. Dec. 10, 2014 - Zacks.com
Pharmaceutical Giant Merck Buys Cubist Pharma 10:04 a.m. Dec. 9, 2014 - GuruFocus.com
Top Global Stocks: Jazz, Actavis In IBD's World List 5:39 p.m. Dec. 8, 2014 - Investors Business Daily
Jazz Pharmaceuticals (JAZZ) Starts Late-Stage Study on Xyrem - Analyst Blog 9:50 a.m. Dec. 3, 2014 - Zacks.com
Top Funds Gobble Up Tech And Medical Stocks 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Enrollment begins in Phase 3 trial for Xyrem expanded label 4:50 p.m. Dec. 2, 2014 - Seeking Alpha
Today's Momo Momentum Stock To Watch: Jazz Pharmaceuticals (JAZZ) 3:24 p.m. Nov. 26, 2014 - TheStreet.com
Insider Trading Alert - INTU, JAZZ And STNR Traded By Insiders 1:01 p.m. Nov. 26, 2014 - TheStreet.com
Riding The Bull Market With These 2 Momentum ETFs 2:10 p.m. Nov. 20, 2014 - Benzinga.com
Four International IBD 50 Stocks Near Buy Points 5:33 p.m. Nov. 19, 2014 - Investors Business Daily
Insider Trading Alert - JAZZ, SSS And PLKI Traded By Insiders 11:45 a.m. Nov. 19, 2014 - TheStreet.com
Five Ethical Drugmakers Keep Leadership Positions 5:27 p.m. Nov. 17, 2014 - Investors Business Daily
Growth Momentum Should Continue For This Pharmaceutical Company 9:50 p.m. Nov. 15, 2014 - GuruFocus.com
Is Jazz Pharmaceuticals (JAZZ) a Great Growth Stock? - Tale of the Tape 9:03 a.m. Nov. 14, 2014 - Zacks.com
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog 4:30 p.m. Nov. 13, 2014 - Zacks.com
Update: Jazz Pharmaceuticals Q3 Earnings 11:00 a.m. Nov. 7, 2014 - Seeking Alpha
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 5, 2014 - Zacks.com

Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease 4:05 p.m. Dec. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update 8:30 a.m. Dec. 9, 2014 - BusinessWire - BZX
Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy 4:05 p.m. Dec. 2, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting 4:05 p.m. Dec. 2, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 4:05 p.m. Nov. 25, 2014 - PR Newswire - PRF
Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo 8:50 a.m. Nov. 10, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Third Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Nov. 4, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014 3:05 p.m. Oct. 21, 2014 - PR Newswire - PRF
Positive Study Results, Dividend, Regulatory Warning, Board Statements, and Technical Updates - Research Reports on Regeneron, CVS Health, Valeant, Allergan and Jazz 8:15 a.m. Oct. 7, 2014 - PR Newswire - PRF
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 8:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 8:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Positive Drug Results, Market Activity Updates, Sustainability Report, Acquisitions, and Plant Closure - Research Reports on Repros, Jazz, Ingersoll-Rand, Nokia and Duke Energy 8:10 a.m. Sept. 2, 2014 - PR Newswire - PRF
Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma 7:50 a.m. Aug. 27, 2014 - PR Newswire - PRF
Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 8:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Box Powers Cloud Collaboration for Leading Life Sciences Organizations 11:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 8:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 8:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 5:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 3:05 p.m. Aug. 6, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CalExitNow Fights Federal Interference in CA Elections

California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...

TECNO CAMON Slim 5G: Where Art Meets Tech

Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...

Tech Breakthroughs in Cancer and Space Energy Aired

Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...

York Space Systems Faces Class Action Over Misleading IPO

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Navimow Powers TOP 14 with Tech: A Winning Play

A Technological Leap for French Rugby Innovation and precision in partnerships—those words don't usually pop up together when chatting about a rugby league. But here we are, discussing the TOP 14, the elite French rugby championship, pairing up with Segway Navimow. This brand, under the umbrella of Ninebot Limited (689009.SH), is stepping into the world of sports for...

TCL’s AI Vision: Immersive Living at IFA 2026

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

VEVOR Unveils New Products at IFA Berlin 2026

VEVOR's Bold Display at IFA Berlin VEVOR isn't shy about making waves at IFA Berlin 2026. The global home improvement heavyweight decided to go all out with an interactive booth that's hard to miss, giving visitors a real taste—sometimes literally—of what they’ve got to offer. This hands-on approach isn't just a gimmick; it’s a clever move to solidify VEVOR's...

Fosun Reaches New Heights in Hang Seng Sustainability

Fosun International's Sustainability Milestone Now, you don't often see a company's sustainability rating climbing the ladder like a homesick angel, but Fosun International just nailed it. On September 7, 2026, their Hang Seng Sustainability Rating bumped up a notch from AA- to AA+, now at an all-time high. It's the sort of financial footnote that grabs the attention....

Hims & Hers Faces Class Action: Investors Beware

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...